Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin.

Antifungal Agents / pharmacology Antiviral Agents / pharmacology Candida / classification Candidiasis / drug therapy Cell Wall / chemistry Drug Resistance, Fungal / genetics Mannans / metabolism Plant Lectins / pharmacology Reactive Oxygen Species / metabolism Recombinant Proteins / pharmacology
Candida Griffithsin Q-Griffithsin antifungal antifungal agents lectins

Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
31 10 2021
Historique:
pubmed: 9 9 2021
medline: 3 2 2022
entrez: 8 9 2021
Statut: ppublish

Résumé

There is a rising global incidence of

Identifiants

DOI: 10.1128/Spectrum.00957-21 PMID: 34494857 PMC: PMC8557872
pubmed: 34494857
doi: 10.1128/Spectrum.00957-21
pmc: PMC8557872
doi:

Substances chimiques

Antifungal Agents 0
Antiviral Agents 0
Mannans 0
Plant Lectins 0
Reactive Oxygen Species 0
Recombinant Proteins 0
q-griffithsin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0095721

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES030283
Pays : United States

Références

Antibiotics (Basel). 2020 Mar 31;9(4):
pubmed: 32244276
F1000 Med Rep. 2011;3:14
pubmed: 21876720
J Clin Microbiol. 2011 Sep;49(9):3139-42
pubmed: 21715586
J Hosp Infect. 2016 Nov;94(3):209-212
pubmed: 27634564
JAMA. 2020 Feb 25;323(8):702
pubmed: 32096859
Int J Mol Sci. 2017 Feb 04;18(2):
pubmed: 28165395
J Antimicrob Chemother. 2000 Aug;46(2):171-9
pubmed: 10933638
J Biol Chem. 2005 Mar 11;280(10):9345-53
pubmed: 15613479
Proteins. 2007 May 15;67(3):661-70
pubmed: 17340634
Mol Immunol. 1982 Mar;19(3):367-73
pubmed: 6178960
Infect Immun. 2000 Aug;68(8):4391-8
pubmed: 10899835
Braz J Microbiol. 2012 Apr;43(2):770-8
pubmed: 24031889
Int J Infect Dis. 2007 May;11(3):239-44
pubmed: 16859945
Front Microbiol. 2020 Jan 09;10:2993
pubmed: 31993032
J Virol. 2010 Mar;84(5):2511-21
pubmed: 20032190
Retrovirology. 2015 Jan 23;12:6
pubmed: 25613831
Infect Immun. 1998 Apr;66(4):1607-12
pubmed: 9529088
Mycoses. 1995 Mar-Apr;38(3-4):111-7
pubmed: 7477085
G3 (Bethesda). 2020 Jan 7;10(1):255-266
pubmed: 31719112
Carbohydr Res. 1988 Dec 31;184:171-82
pubmed: 3149545
Antibiotics (Basel). 2020 Jul 25;9(8):
pubmed: 32722455
Sci Rep. 2017 Jul 18;7(1):5693
pubmed: 28720847
Clin Microbiol Infect. 2008 Apr;14(4):398-405
pubmed: 18190574
J Biol Chem. 1995 Jan 20;270(3):1113-22
pubmed: 7836369
Mol Biol Cell. 2003 Apr;14(4):1460-7
pubmed: 12686601
Clin Infect Dis. 2017 Jan 15;64(2):134-140
pubmed: 27988485
Sci Rep. 2018 May 23;8(1):8059
pubmed: 29795295
mSphere. 2016 Aug 18;1(4):
pubmed: 27547827
Am J Transplant. 2017 Jan;17(1):296-299
pubmed: 28029734
Phytomedicine. 2019 May;58:152875
pubmed: 30884454
AAPS PharmSciTech. 2021 Feb 24;22(3):83
pubmed: 33625602
Emerg Infect Dis. 2017 Jan;23(1):162-164
pubmed: 27983941
Biochem J. 2007 Jun 15;404(3):365-72
pubmed: 17331070
Structure. 2010 Sep 8;18(9):1104-15
pubmed: 20826337
Front Microbiol. 2017 Jan 12;7:2173
pubmed: 28127295
Int J Mol Sci. 2011 Feb 17;12(2):1187-95
pubmed: 21541052
Infect Drug Resist. 2020 May 05;13:1287-1294
pubmed: 32440165
Protein Sci. 2007 Jul;16(7):1485-9
pubmed: 17567736
Indian J Med Microbiol. 2013 Jan-Mar;31(1):90-1
pubmed: 23508441
J Infect Dis. 2017 Aug 15;216(suppl_3):S445-S451
pubmed: 28911043
Nat Rev Drug Discov. 2010 Sep;9(9):719-27
pubmed: 20725094
Genome Med. 2011 Mar 04;3(3):14
pubmed: 21392406
Genes (Basel). 2018 Sep 19;9(9):
pubmed: 30235884
Curr Protoc Immunol. 2015 Nov 02;111:A3.B.1-A3.B.3
pubmed: 26529666
Adv Genet. 2013;81:33-82
pubmed: 23419716
J Clin Gastroenterol. 2014 Jul;48(6):513-23
pubmed: 24275714
APMIS. 1995 Oct;103(10):714-20
pubmed: 8534430
Structure. 2006 Jul;14(7):1127-35
pubmed: 16843894
J Antimicrob Chemother. 2017 Jun 1;72(6):1794-1801
pubmed: 28333181
Curr Opin Gastroenterol. 2015 Jan;31(1):69-75
pubmed: 25394236
Biomed Res Int. 2018 May 8;2018:3750646
pubmed: 29854749
Mem Inst Oswaldo Cruz. 2001 Jul;96(5):673-8
pubmed: 11500769
MMWR Morb Mortal Wkly Rep. 2017 May 19;66(19):514-515
pubmed: 28520710
Curr HIV Res. 2012 Apr;10(3):211-7
pubmed: 22384840
Med Mycol. 2000 Apr;38(2):155-9
pubmed: 10817232
Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(6):250-65
pubmed: 22728440
Sex Transm Dis. 2001 Jun;28(6):347-8
pubmed: 11403193
J Intensive Care. 2018 Oct 29;6:69
pubmed: 30397481
Can J Microbiol. 1980 Apr;26(4):468-74
pubmed: 6155190
Nat Rev Immunol. 2017 Oct;17(10):635-646
pubmed: 28604735
MMWR Morb Mortal Wkly Rep. 2020 Jan 10;69(1):6-9
pubmed: 31917780
Clin Infect Dis. 2012 May;54(9):1240-8
pubmed: 22431804
J Clin Microbiol. 2008 Feb;46(2):515-21
pubmed: 18077633
ACS Infect Dis. 2020 May 8;6(5):1018-1031
pubmed: 32233507
Clin Pharmacokinet. 1992 Oct;23(4):279-91
pubmed: 1395361
J Infect Dis. 2020 May 11;221(Supplement_4):S480-S492
pubmed: 32037447
Nucleic Acids Res. 2021 Jan 8;49(D1):D394-D403
pubmed: 33290554
J Antimicrob Chemother. 2014 Nov;69(11):3134-41
pubmed: 24970743
Antimicrob Agents Chemother. 1975 May;7(5):704-11
pubmed: 1096812
Sci Rep. 2018 Nov 20;8(1):17123
pubmed: 30459422
Trends Microbiol. 2003 Jun;11(6):272-9
pubmed: 12823944
Mycoses. 2018 Jul;61(7):498-505
pubmed: 29655180
Eur J Clin Microbiol Infect Dis. 2014 Jun;33(6):919-26
pubmed: 24357342
Front Microbiol. 2019 Aug 20;10:1918
pubmed: 31481947
J Infect Public Health. 2019 Jul - Aug;12(4):451-459
pubmed: 31000491
BMC Infect Dis. 2013 Feb 12;13:82
pubmed: 23398783
Plant Biotechnol J. 2015 Oct;13(8):1160-8
pubmed: 26176205
FEBS J. 2012 May;279(10):1844-56
pubmed: 22404982

Auteurs

Henry W Nabeta (HW)

Department of Microbiology and Immunology, School of Medicine, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA.
Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA.
ORCID: 0000-0003-0351-507X

Joseph C Kouokam (JC)

Department of Pharmacology and Toxicology, School of Medicine, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA.

Amanda B Lasnik (AB)

Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA.

Joshua L Fuqua (JL)

Department of Pharmacology and Toxicology, School of Medicine, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA.
Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA.

Kenneth E Palmer (KE)

Department of Pharmacology and Toxicology, School of Medicine, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA.
Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisvillegrid.266623.5, Louisville, Kentucky, USA.

Articles similaires

Advances research in porcine enteric coronavirus therapies and antiviral drugs.

Jixiang Liang, Weihang Xu, Xiaoming Pan et al.
1.00
Animals Swine Antiviral Agents Swine Diseases Coronavirus Infections

Menthol as an effective inhibitor of quorum sensing and biofilm formation in Candida albicans and Candida glabrata by targeting the transcriptional repressor TUP1.

Pouria Khodavandi, Maryam Miri Soogh, Fahimeh Alizadeh et al.
1.00
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Trends in hepatocellular carcinoma and viral hepatitis treatment in older Americans.

Joy Jiang, Meredith S Shiels, Donna Rivera et al.
1.00
Humans Carcinoma, Hepatocellular Liver Neoplasms Aged United States

Two codependent routes lead to high-level MRSA.

Abimbola Feyisara Adedeji-Olulana, Katarzyna Wacnik, Lucia Lafage et al.
1.00
Methicillin-Resistant Staphylococcus aureus Penicillin-Binding Proteins Peptidoglycan Bacterial Proteins Anti-Bacterial Agents

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antifongiques › Novel Antifungal Activity of Q-Griffithsin, a...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antiviraux › Novel Antifungal Activity of Q-Griffithsin, a...
questionsmedicales.fr › Eucaryotes › Champignons › Levures › Candida › Novel Antifungal Activity of Q-Griffithsin, a...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Mycoses › Candidose › Novel Antifungal Activity of Q-Griffithsin, a...
questionsmedicales.fr › Cellules › Structures cellulaires › Paroi cellulaire › Novel Antifungal Activity of Q-Griffithsin, a...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance des champignons aux médicaments › Novel Antifungal Activity of Q-Griffithsin, a...
questionsmedicales.fr › Glucides › Polyosides › Mannanes › Novel Antifungal Activity of Q-Griffithsin, a...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines végétales › Lectines végétales › Novel Antifungal Activity of Q-Griffithsin, a...
questionsmedicales.fr › Produits chimiques inorganiques › Composés de l'oxygène › Espèces réactives de l'oxygène › Novel Antifungal Activity of Q-Griffithsin, a...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines recombinantes › Novel Antifungal Activity of Q-Griffithsin, a...